Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 94,281 | 80,879 | 61,553 | 61,800 | 78,477 |
| Operating Income | -94,281 | -80,879 | -61,553 | -61,800 | -78,477 |
| Other Income | 7,208 | 5,792 | 10,027 | 3,592 | 4,529 |
| Pre-tax Income | -87,073 | -75,087 | -51,526 | -58,208 | -73,948 |
| Income Tax | 77 | 232 | -108 | 454 | -11 |
| Net Income Continuous | -87,150 | -75,319 | -51,418 | -58,662 | -73,937 |
| Net Income | $-87,150 | $-75,319 | $-51,418 | $-58,662 | $-73,937 |
| EPS Basic Total Ops | -0.60 | -0.50 | -0.36 | -0.45 | -0.57 |
| EPS Basic Continuous Ops | -0.60 | -0.51 | -0.36 | -0.45 | -0.57 |
| EPS Diluted Total Ops | -0.60 | -0.50 | -0.36 | -0.45 | -0.57 |
| EPS Diluted Continuous Ops | -0.60 | -0.51 | -0.36 | -0.45 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.52 | -0.36 | -0.45 | N/A |
| EBITDA(a) | $-94,201 | $-80,815 | $-61,495 | $-61,800 | $-78,477 |